STANDARD BIOTOOLS INC. — Director's Dealing 2022

Aug 24, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-08-22

Reporting Person: JOG VIKRAM (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-22	Common Stock	M	3130	—	Acquired	164881	Direct
2022-08-22	Common Stock	M	2390	—	Acquired	167271	Direct
2022-08-22	Common Stock	M	2236	—	Acquired	169507	Direct
2022-08-22	Common Stock	F	2681	$1.56	Disposed	166826	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-22	Restricted Stock Units	$	M	3130	Disposed		Common Stock (3130.0)	Direct
2022-08-22	Restricted Stock Units	$	M	2390	Disposed		Common Stock (2390.0)	Direct
2022-08-22	Restricted Stock Units	$	M	2236	Disposed		Common Stock (2236.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	52061	Indirect

Footnotes

F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to an additional 1/16th of the total number of shares each quarter thereafter.

F4: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.

F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.